TCM
CANC icon

TD Capital Management’s Tema Oncology ETF CANC Stock Holding History

TD Capital Management’s Portfolio CANC Stock Details CANC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8K Hold
376
– – ﹤0.01% 428
2025
Q4 		$13.1K Hold
376
– – ﹤0.01% 419
2025
Q3 		$10.8K Buy
+376
New +$9.99K ﹤0.01% 409

Other funds holding CANC

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
WF
Willow Financial Rogers, Arkansas $98.7M AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
PIA
Perennial Investment Advisors Los Angeles, California $1.26B AUM 22.26% 1-Year Est. Return
RF
Roxbury Financial Mount Arlington, New Jersey $126M AUM 23.88% 1-Year Est. Return

TD Capital Management's CANC Position: Q1 2026 in Review

TD Capital Management held its Tema Oncology ETF (CANC) position steady in Q1 2026 at 376 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

TD Capital Management first reported a position in CANC in Q3 2025 and has held it in 3 quarters since. 12 funds tracked by Wall St. Rank hold CANC as of Q1 2026.

  • TD Capital Management held 376 shares of Tema Oncology ETF worth $13.8K as of Q1 2026.
  • TD Capital Management left its Tema Oncology ETF share count unchanged in Q1 2026.
  • Tema Oncology ETF made up ﹤0.01% of TD Capital Management's portfolio in Q1 2026, its #428 holding.
  • TD Capital Management first reported a position in Tema Oncology ETF in Q3 2025 and has held it in 3 quarters since.
  • 12 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.